Investigating the efficacy of monovalent and tetravalent dengue vaccine formulations against DENV-4 challenge in AG129 mice

Dengue (DEN) is the most important mosquito-borne viral disease, with a major impact on global health and economics, caused by four serologically and distinct viruses termed DENV-1 to DENV-4. Currently, there is no licensed vaccine to prevent DEN. We have developed a live attenuated tetravalent DENV...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Vaccine
Autores principales: Fuchs, Jeremy, Chu, Haiyan, O'Day, Peter, Pyles, Richard, Bourne, Nigel, Das, Subash C., Milligan, Gregg N., Barrett, Alan D.T., Partidos, Charalambos D., Osorio, Jorge E.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2014
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4252871/
https://ncbi.nlm.nih.gov/pubmed/25239488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2014.08.087
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares